Strong protective effect of theAPOL1p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease
focal segmental glomerulosclerosis
Genotype
Glomerulosclerosis, Focal Segmental
Science
Q
Apolipoprotein L1
Article
3. Good health
Apolipoproteins
genotypes
Risk Factors
Humans
Genetic Predisposition to Disease
Apolipoprotein L1; Apolipoproteins; Genetic Predisposition to Disease; Genotype; Glomerulosclerosis, Focal Segmental; Humans; Risk Factors
chronic kidney disease
DOI:
10.1101/2023.08.02.23293554
Publication Date:
2023-08-05T06:00:36Z
AUTHORS (80)
ABSTRACT
ABSTRACTBlack Americans have a significantly higher risk of developing chronic kidney disease (CKD), especially focal segmental glomerulosclerosis (FSGS), than European Americans. Two coding variants (G1 and G2) in theAPOL1gene play a major role in this disparity. While 13% of Black Americans carry the high-risk recessive genotypes, only a fraction of these individuals develops FSGS or kidney failure, indicating the involvement of additional disease modifiers.Here, we show that the presence of theAPOL1p.N264K missense variant, when co-inherited with the G2APOL1risk allele, substantially reduces the penetrance of the G1G2 and G2G2 high-risk genotypes by rendering these genotypes low-risk. These results align with prior functional evidence showing that the p.N264K variant reduces the toxicity of theAPOL1high-risk alleles. These findings have important implications for our understanding of the mechanisms ofAPOL1-associated nephropathy, as well as for the clinical management of individuals with high-risk genotypes that include the G2 allele.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (18)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....